Establishment of screening models for selective cyclooxygenase-2 inhibitors

Yaoxue Xuebao

Volumn 35, Issue 5, 2000, Pages 343-346

  Hu, Yu Fang ^a   Cheng, Gui Fang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Cyclooxygenase 1; Cyclooxygenase 2; Nonsteroidal antiinflammatory drugs; Selective cyclooxygenase inhibitor

Indexed keywords

EID: 0041407189     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Vane JR. Induction of prostaglandin synthesis as a mechanism of action for aspirin-like drugs [J] . Natl New Biol, 1971,231:232.
2. Vane JR. New insight into the mode of action of antiinflammatory drugs [J]. Inflamm Res, 1995,44:1.
3. Cirino G. Multiple controls in inflammation [J]. Biochem Pharmacol, 1998,55:105.
4. Mitchell JA, Akarasereenont P, Thiemermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase [J]. Proc Natl Acad Sci USA, 1994,90:11693.
5. Nucci G, Gryglewski RJ, Warner TD, et al. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled [J]. Proc Natl Acad Sci USA, 1988,85:2334.
6. Engelhardt G, Bögel R, Schnitzer C, et al. Meloxican: influence on arachidonic acid metabolism, part I [J]. in vitro findings. Biochem Pharmacol, 1996,51:21.